John C.K. Milligan, IV

2018

In 2018, John C.K. Milligan, IV earned a total compensation of $1.7M as President and Secretary at TherapeuticsMD, a 8% decrease compared to previous year.

Compensation breakdown

Bonus$78,750
Non-Equity Incentive Plan$315,000
Option Awards$832,225
Salary$450,000
Other$25,459
Total$1,701,434

Milligan received $832.2K in option awards, accounting for 49% of the total pay in 2018.

Milligan also received $78.8K in bonus, $315K in non-equity incentive plan, $450K in salary and $25.5K in other compensation.

Rankings

In 2018, John C.K. Milligan, IV's compensation ranked 6,552nd out of 14,244 executives tracked by ExecPay. In other words, Milligan earned more than 54.0% of executives.

ClassificationRankingPercentile
All
6,552
out of 14,244
54th
Division
Manufacturing
2,509
out of 5,765
57th
Major group
Chemicals And Allied Products
936
out of 2,128
56th
Industry group
Drugs
784
out of 1,817
57th
Industry
Pharmaceutical Preparations
611
out of 1,391
56th
Source: SEC filing on April 29, 2019.

Milligan's colleagues

We found four more compensation records of executives who worked with John C.K. Milligan, IV at TherapeuticsMD in 2018.

2018

Robert Finizio

TherapeuticsMD

Chief Executive Officer

2018

Daniel Cartwright

TherapeuticsMD

Chief Financial Officer

2018

Mitchell Krassan

TherapeuticsMD

Chief Strategy Performance Officer

2018

Michael Donegan

TherapeuticsMD

Vice President - Finance

News

You may also like